Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
Schestatsky
Pedro
P
Picon
Paulo Dornelles
PD
D000208:Acute Disease / Q000628:therapy; D002545:Brain Ischemia / Q000188:drug therapy*; D004632:Emergency Medical Services / Q000592:standards / Q000706:statistics & numerical data; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000379:methods / Q000592:standards* / Q000706:statistics & numerical data*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D028761:Withholding Treatment / Q000592:standards
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator